Trademark: 88304845
Word
ALTIMI
Status
Dead
Status Code
602
Status Date
Sunday, September 19, 2021
Serial Number
88304845
Mark Type
4000
Filing Date
Sunday, February 17, 2019
Published for Opposition
Tuesday, December 15, 2020
Abandoned Date
Wednesday, September 8, 2021

Trademark Owner History
Altimi Biosciences, Inc. - Owner At Publication

Classifications
5 House mark for a full line of pharmaceuticals and pharmaceutical preparations, namely, pharmaceutical preparations and substances used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, dermatological, pulmonary, respiratory, oncological, hepatological, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, endocrine, neurological, sleep, muscular, and psychiatric diseases and disorders;pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, polymyalgia rheumatic, spondyloarthropathies, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, autoimmune pancreatitis, multiple myeloma, multiple sclerosis, systemic lupus erythematosus, lupus nephritis, chronic inflammatory demyelinating polyneuropathy, autoimmune anemia, autoimmune hemolytic anemia, pure red cell aplasia, idiopathic thrombocytopenic purpura, Evans syndrome, type 1 diabetes mellitus, Sjogren's syndrome, encephalitis, IgG4-related disease, Devic's disease, myositis, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, palmoplantar psoriasis, hidradenitis suppurativa, bullous skin disorder, pemphigus, pemphigoid, kawasaki disease, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, age-related macular degeneration, refractory diabetic macular edema, uveitis, childhood uveitis, uveitic macular edema, choroidal neovascularization, Graves' ophthalmopathy, pyoderma gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancer, breast cancer, ovarian cancer, cervical cancer, gastric cancer, colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, head and neck cancer, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, lymphocyte predominant subtype of Hodgkin's Lymphoma, vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, graft-versus-host disease, graft-versus-host disease following allogenic hematopoietic stem cell transplantation, graft-versus-host disease following keratoprosthesis, kidney transplant, asthma, chronic fatigue syndrome, major depression, and bipolar depression

Trademark Events
Sep 20, 2021
Abandonment Notice E-Mailed - Failure To Respond
Sep 19, 2021
Abandonment - Failure To Respond Or Late Response
Mar 7, 2021
Notification Of Non-Final Action E-Mailed
Mar 7, 2021
Non-Final Action E-Mailed
Mar 7, 2021
Su - Non-Final Action - Written
Mar 2, 2021
Statement Of Use Processing Complete
Feb 10, 2021
Use Amendment Filed
Mar 1, 2021
Case Assigned To Intent To Use Paralegal
Feb 10, 2021
Teas Statement Of Use Received
Feb 9, 2021
Noa E-Mailed - Sou Required From Applicant
Dec 15, 2020
Official Gazette Publication Confirmation E-Mailed
Dec 15, 2020
Published For Opposition
Nov 25, 2020
Notification Of Notice Of Publication E-Mailed
Nov 10, 2020
Approved For Pub - Principal Register
May 10, 2020
Report Completed Suspension Check Case Still Suspended
Nov 3, 2019
Report Completed Suspension Check Case Still Suspended
Apr 29, 2019
Notification Of Letter Of Suspension E-Mailed
Apr 29, 2019
Letter Of Suspension E-Mailed
Apr 29, 2019
Suspension Letter Written
Apr 29, 2019
Assigned To Examiner
Mar 10, 2019
New Application Office Supplied Data Entered In Tram
Feb 20, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24